# LUPKYNIS Drug-use Results Survey

> **NCT07053891** · — · RECRUITING · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 400 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Voclosporin (LUPKYNIS)

## Key facts

- **NCT ID:** NCT07053891
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-17
- **Primary completion:** 2031-06-30
- **Final completion:** 2032-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07053891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07053891, "LUPKYNIS Drug-use Results Survey". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07053891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*